PAR paradigm biopharmaceuticals limited..

Ann: Appendix 4D and Half Year Report, page-20

  1. 18,474 Posts.
    lightbulb Created with Sketch. 5257
    And how many of those have performed as well as PAR has recently? I can give you several larger healthcare stocks off the top of my head that are down similar amounts, NEU, TLX. If you expect lots of 8%+ up days (as we have had several of recently) you have to be ready to cop a few of those going the other way, especially when the market is taking a big beating. People obsess way too much over the day to day share price swings, for some reason a lot more on the down days than on equivalent up days. Who cares about the past 4 years, is it the same company now as it was back then? My example was merely to reflect on how sentiment magically shifted between the very recent ups and downs of the share price without and fundamentals changes that warranted such shifts in sentiment.

    Im not going to sit around and argue with people who want to obsess over every little price change though, if you want to worry then go ahead, my post was to show how pointless such a discussion is as this process repeats every single time. The price rises, “this is the best stock in the world it’s going to $1”, the price falls, “it’s all over”, the price rises… it repeats. Discussion over, enjoy your weekend and stop stressing about price movements
    Last edited by TheAnalyst007: 28/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
0.000(0.00%)
Mkt cap ! $170.8M
Open High Low Value Volume
43.0¢ 43.0¢ 41.5¢ $141.6K 337.6K

Buyers (Bids)

No. Vol. Price($)
1 9738 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 76716 4
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.